Epigenome Technologies, Inc. specializes in single-cell multi-omics technologies to study the epigenome in normal and disease states: epigenomics. The company's proprietary technology, Paired-Tag, can jointly profile histone marks and gene expression from up to 1 million single cells in parallel The technique does not require droplet-based single cell genomics platforms and is therefore generally adaptable by molecular biology laboratories everywhere.
